Toumaz Technology Chairman and Chief Technology Officer Elected to Prestigious Fellowship of Royal Society
Professor Chris Toumazou Honoured as Fellow of UK’s National Academy of Science

Toumaz Technology Limited, the leading provider of ultra-low power wireless infrastructure for body monitoring solutions, today announces that Toumaz Co-Founder, Chairman and Chief Technology Officer Professor Chris Toumazou has been elected as a Fellow of the Royal Society – the highest honour in the UK scientific system. The Royal Society is the national academy of science for the UK and Commonwealth and is the world’s oldest scientific academy in continuous existence. The Royal Society counts the world’s most eminent scientists among its Fellowship and Foreign Membership, which has included Isaac Newton, Charles Darwin, Albert Einstein and Stephen Hawking.

Professor Toumazou FRS co-founded Toumaz Technology in 2000 to exploit developments in ultra-low power silicon chip technology at Imperial College London. The patented core technology, Advanced Mixed Signal Processing (AMx™), is the basis for Toumaz’s Sensium™ technology platform for intelligent wireless body monitoring.

Professor Toumazou currently holds the Winston Wong Chair in Biomedical Circuits at Imperial College London and is Director and Chief Scientist of the new Institute of Biomedical Engineering at Imperial. In recognition of his outstanding research, he was made a Professor at Imperial at the age of 33 – one of the youngest ever. He holds 23 patents, many of which are now fully granted in key territories throughout the world, and has published over 320 research papers in the field of RF and low power electronics.

Professor Toumazou led a major campaign to raise £22 million to fund the creation of the Institute of Biomedical Engineering at Imperial College, which opened its state-of-the-art, purpose-built facilities in 2006. By combining the strengths of Imperial’s world class research schools in engineering and medicine, the IBE draws together scientists, medical researchers, clinicians and engineers to drive major advances in key areas of medical diagnosis and treatment, including personalised healthcare, regenerative medicine and biomedical imaging.

Shalini /ITvoirNetwork